Diosmin
This article was originally published in The Tan Sheet
Executive Summary
Nutratech's premarket notification for new dietary ingredient for venal health supplement rejected by FDA in mid-June. Diosmin already is sold in the U.S. and internationally, the Fairfield, N.J.-based marketer says. In a June 16 letter, the agency voices "significant concerns" about safety. Nutratech has since submitted additional clarification and clinical data to FDA
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: